1051375-19-9|Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate|BLD Pharm

Accueil/ Inhibitors/Agonists/ Anti-infection/ HIV Integrase/ Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate

Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate *Cold-chain transportation

CAS NO.： 1051375-19-9

Taille	Prix	Sale Price	Remise	Stock-CN	Stock-US	Stock-IND	Stock-EU	Quantité

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

INFORMATION PRODUIT

détails du produit
Sécurité

Nom du produit :	Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
CAS NO. :	1051375-19-9	Masse moléculaire :	441.36
MDL NO. :	MFCD28405599	Pureté/Spécification :
Formule moléculaire :	C₂₀H₁₈F₂N₃NaO₅	Stockage :	Inert atmosphere,2-8°C
Point d'ébullition :	No data available

GHS Pictogram :
Signal Word :	Warning	Precautionary Statements :	P261-P305+P351+P338
UN# :	-	Class :	-
Hazard Statements :	H302-H315-H319-H335	Packing Group :	-

Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate *Cold-chain transportation

INFORMATION PRODUIT

PRODUITS CONNEXES

RECORDS HISTORIQUES

Contactez-nous